(Q84096918)

English

Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis

scientific article published on 11 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

Leishmania infantum

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Maria Agallou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Maritsa Margaroni

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Evdokia Karagouni

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

11 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

5053-5064

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Dendritic cells: are they clinically relevant?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Directing dendritic cell immunotherapy towards successful cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Mechanisms of dendritic cell-based vaccination against infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Leishmaniasis in the World Health Organization Eastern Mediterranean Region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Leishmaniasis: current situation and new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Clinical and experimental advances in treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

T-cell and cytokine responses in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Type 1 and type 2 responses to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Immunity and immunosuppression in experimental visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

The expression of the Leishmania infantum KMP-11 protein is developmentally regulated and stage specific.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generati

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Humoral and Cellular Immune Responses to Synthetic Peptides of the Leishmania donovani Kinetoplastid Membrane Protein-11

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Function of CD8+ T lymphocytes in a self-curing mouse model of visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

ISCOMs vaccine against experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Immunohistological features of visceral leishmaniasis in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Abundant empty class II MHC molecules on the surface of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Extracellular antigen processing and presentation by immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

IL-17 and Th17 Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

The biological functions of T helper 17 cell effector cytokines in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Proinflammatory T helper type 17 cells are effective B-cell helpers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

A critical role for IL-21 in regulating immunoglobulin production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Leishmania infantum: mixed T-helper-1/T-helper-2 immune response in experimentally infected BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Identification of regulatory T cells during experimental Leishmania infantum infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Innate IL-17-producing cells: the sentinels of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

Kinetoplastid membrane protein-11 is present in promastigotes and amastigotes of Leishmania amazonensis and its surface expression increases during metacyclogenesis

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

based on heuristic

inferred from DOI database lookup

The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.089

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.04.089

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21569815%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84096918&oldid=1984653110"